Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes
|
By HospiMedica International staff writers Posted on 16 Nov 2022 |

Absology Co., Ltd. (Gyeonggi-do, Korea) is participating in MEDICA 2022 where the company is exhibiting its POC FIA (Fluorescence Immunoassay) analyzer that uses microfluidic technology for the accurate quantitative diagnosis of concentration of biomarkers for a range of diseases.
At MEDICA 2022, Absology is showcasing its ABSOL POCT analyzer that uses FIA technology to quantitatively diagnose the concentration of biomarkers. It has a test time of only five minutes and features a vivid expressed GUI along with a convenient built-in printer. Alongside ABSOL, the company is showcasing the ABSOL HS high-sensitive ELISA analyzer for early disease screening. ABSOL HS can detect Femtogram level molecules using Absology’s proprietary PIFA (Photooxidation Induced Fluorescence Amplification) technology. It has a test time of only 30 minutes and requires just 20uL of blood sample. Compact and affordable, the portable and light weight ABSOL HS is a flexible platform for any kind of ELISA protocol. Absology offers a wide test menu for the ABSOL and ABSOL HS systems, including PSA, Testosterone, Vitamin D, TSH, FreeT4, Thyroid Combo, Cortisol, PCT, COVID-19 IgM/IgG, COVID-19 Ag, COVID-19 Neutralizing Antibody, and Influenza A/B.
Related Links:
Absology Co., Ltd.
Latest MEDICA 2022 News
Channels
Artificial Intelligence
view channel
AI Model Identifies Rare Endocrine Disorder from Hand Images
Acromegaly is a rare, intractable disease that typically begins in middle age and causes enlargement of the hands and feet, changes in facial appearance, and abnormal bone and organ growth.... Read moreCritical Care
view channel
AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Heart failure remains one of the leading causes of illness and death worldwide, with nearly half of patients dying within five years of diagnosis. Despite advances in treatment, predicting how a patient’s... Read more
Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Out-of-hospital cardiac arrest carries a high risk of death, with survival rates below 10%. Even when the heart is restarted, clinicians often face uncertainty about the extent of brain injury.... Read moreSurgical Techniques
view channel
Handheld Robotic System Expands Options for Total Knee Surgery
Orthopedic teams vary in their adoption of robotics, with some surgeons favoring intraoperative decision-making and a manual instrument feel, while others rely on preoperative, computed tomography–based... Read more
VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
Many patients experience anxiety and limited comprehension when preparing for invasive or device-assisted care. Complex consent materials can leave people uncertain about risks, benefits, and what to expect... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channelMedtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
Medtronic announced a multiyear renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on more than three decades of collaboration,... Read more
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more








